跳至主要内容
临床试验/NL-OMON39492
NL-OMON39492已完成不适用

The use of activated Platelet Rich Plasma (PRP) in human autologous fat transfer. - The use of Platelet Rich Plasma (PRP) in human autologous fat transfer.

Bergman Clinics0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Aged 45-65
  • * Stable normal BMI (20-25) (1 year stable between 20-25)

排除标准

  • * Aged below 45 or above 65 years
  • * Aged between 45 and 55 and in the menopause
  • * Aged between 55 and 65 and pre-menopause
  • * Prior operations in the mid-face
  • * Any oncological event in the patients history
  • * A known psychiatric condition
  • * A known systemic disease that will impair wound healing ( eg diabetus mellitus, known atherosclerosis with an event that required hospitalization, collagen diseases, diseases of the skin).
  • * BMI <20 or >25 or an unstable BMI: 1 year ± 5 points.
  • - Pregnancy or active child wish
  • - Frequent exposure to known carcinogenic substances ( eg. work related).
  • * Active or previous use of hormone replacement therapy.

研究者

发起方
Bergman Clinics

相似试验